Theravance Biopharma, Inc. (TBPH)

NASDAQ: TBPH · Real-Time Price · USD

13.81

-0.22 (-1.57%)

At close: Mar 11, 2026, 4:00 PM EDT

13.80

-0.01 (-0.07%)

After-hours: Mar 11, 2026, 4:10 PM EDT

Theravance Biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	29.34	-56.42	-55.19	872.13	-199.43	-278.02
Depreciation & Amortization	1.65	1.71	2	3.72	4.8	4.71
Stock-Based Compensation	19.82	21.39	25.37	39.73	62.06	62.98
Other Adjustments	-13.09	1.43	9.16	4.6	1.98	2.17
Change in Receivables	-1.42	-0.97	-0.69	-2.72	1.8	6.13
Changes in Accounts Payable	0.76	0.75	0.01	-1.61	-3.53	3.66
Changes in Accrued Expenses	8.28	1.47	-7.1	-15.33	-37.23	5.98
Changes in Income Taxes Payable	-4.6	9.91	1.1	63.95	-0.19	-8.54
Changes in Unearned Revenue	-	-	-0.22	-0.19	-11.46	-26.47
Changes in Other Operating Activities	146.24	9.2	-1.45	-1.75	11.06	-18.54
Operating Cash Flow	243.7	-11.54	-27	-186.99	-207.86	-250.4
Capital Expenditures	-0.22	-0.33	-2.49	-0.57	-3.41	-6.62
Sale of Property, Plant & Equipment	-	-	1.51	1.87	0.01	0.06
Purchases of Investments	-221.01	-143.04	-134.53	-103.15	-158.31	-401.99
Proceeds from Sale of Investments	117.5	155.65	102.81	158.02	286.2	419.26
Proceeds from Business Divestments	-	-	-	2.71	-	-
Investing Cash Flow	-90.19	12.28	-32.7	1,154	124.49	10.72
Long-Term Debt Issued	-	-	-	24.46	-	380
Long-Term Debt Repaid	-	-	-	-631.6	-10.73	-235.35
Net Long-Term Debt Issued (Repaid)	-	-	-	-607.14	-10.73	144.65
Issuance of Common Stock	0.18	0.61	0.62	0.8	111.65	144.98
Repurchase of Common Stock	-2.58	-3.1	-199.55	-132.28	-9.06	-9.75
Net Common Stock Issued (Repurchased)	-2.39	-2.5	-198.93	-131.48	102.59	135.23
Financing Cash Flow	-2.12	-2.5	-198.93	-758.81	91.86	263.09
Net Cash Flow	151.4	-1.75	-258.63	208.21	8.5	23.4
Free Cash Flow	243.48	-11.87	-29.49	-187.56	-211.26	-257.02
FCF Margin	303.11%	-18.43%	-51.35%	-365.29%	-381.96%	-357.68%
Free Cash Flow Per Share	4.83	-0.24	-0.53	-2.55	-3.04	-4.12
Levered Free Cash Flow	181.41	-33.72	-63.33	313.21	-250.11	-179.18
Unlevered Free Cash Flow	164.78	-11.83	-57.44	133.59	-297.59	-335.08

Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q